Replimune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.
CEOSushil Patel
CEOSushil Patel
Employees479
Employees479
HeadquartersWoburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded2015
Founded2015
Employees479
Employees479
REPL Key Statistics
Market cap649.84M
Market cap649.84M
Price-Earnings ratio-2.62
Price-Earnings ratio-2.62
Dividend yield—
Dividend yield—
Average volume1.55M
Average volume1.55M
High today$9.00
High today$9.00
Low today$8.15
Low today$8.15
Open price$8.41
Open price$8.41
Volume1.09M
Volume1.09M
52 Week high$17.00
52 Week high$17.00
52 Week low$4.92
52 Week low$4.92
REPL News
TipRanks 5d
Replimune Group’s Internal Control Weaknesses Threaten Financial Stability and Investor ConfidenceReplimune Group (REPL) has disclosed a new risk, in the Accounting & Financial Operations category. Confident Investing Starts Here: Easily unpack a company's...
TipRanks 7d
Replimune reports Q4 EPS ($3.07), consensus (69c)“As we near our PDUFA date, our commercial organization is now fully hired and ready to execute our first launch in advanced melanoma,” said Sushil Patel, Ph.D....
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.